Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将病细胞与化疗药物微孔液体培养,MTT法检测细胞毒性。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将病细胞与化疗药物微孔液体培养,MTT法检测细胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为病药物疗效标志,被
评
患者危险,在某些病例中也
整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将白血病胞与化疗药物微孔液体培养,MTT法
胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用于评患者危险,在某些病例中也用于调整治疗强度。
:
上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将白血病细胞与化疗药物微孔液体培养,MTT法检测细胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用于评患者危险,在某些病例中也用于调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将白血细胞与化
药
微孔液体培养,MTT法检测细胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血药
标志,被用于评
患者危险,在某
中也用于调整治
强度。
声明:以上句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将细胞与化疗药物微孔液体培养,MTT法检测细胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗药物疗效标志,被用于评
患者危险,在某些
例中也用于调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将白血病细胞与化疗药物微孔液体培养,MTT法检测细胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标,
于评
患者
,
某些病例中也
于调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将白细胞与化疗药物微孔液体培养,MTT法检测细胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白药物疗效标志,被用于评
患者危险,在某些
例中也用于调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将白血病细胞与化药物微孔液体培养,MTT法检测细胞毒
。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD抗白血病药物
效标志,被用于评
患者危险,在某些病例中也用于调
强度。
声明:以上例句、词分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.
将白血病细胞与化疗药物微孔液体培养,MTT法检测细胞毒性。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用于评患者危险,在某些病例中也用于调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其容亦不代
本软件的观点;若发现问题,欢迎向我们指正。